PDL BioPharma Announces Successful Conclusion of Agreement with Avinger
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
PDL BioPharma (PDLI) Completes Structured Financing Agreement with Avinger (AVGR)
September 23, 2015 7:02 AM EDTPDL BioPharma (NASDAQ: PDLI) announced that PDL has received approximately $21.4 million in connection with the termination of PDL's structured financing agreement with Avinger, Inc. (Nasdaq: AVGR), which included repayment of the full principal amount outstanding of $20.6 million as... More
Avinger (AVGR) Enters $55M Financing Arrangement
September 23, 2015 7:01 AM EDTAvinger (NASDAQ: AVGR) announced that it has entered into a term loan agreement and a securities purchase agreement with CRG (formerly Capital Royalty L.P.). The agreements provide Avinger with new financing of up to $55.0 million.
Under the terms of the term loan agreement, Avinger initially borrowed $30.0 million, which requires only interest payments for four years. Concurrent with this first tranche, CRG purchased $5.0 million in shares of... More
